CES 2023 kicks off this Thursday in Las Vegas. Here’s what to know ahead of the consumer electronics trade show.
Author: Bailey Schulz, USA TODAY
Eggs are up 50% from last year. How much is inflation hitting your holiday meals?
While inflation is starting to slow, grocery prices are 12% above where they were this time last year according to the Bureau of Labor Statistics.
Coal consumption set to reach record high in 2022 amid global energy crisis
A global energy crisis has pushed countries to turn toward coal to generate power, according to a Friday report from the International Energy Agency.
Pharmacies are cutting hours and closing stores. What it means for customers.
Pharmacies across the country have been cutting back hours and shuttering stores, which may hinder access to prescriptions.
FTX founder arrested in Bahamas: How Sam Bankman-Fried’s alleged scheme unraveled
Sam Bankman-Fried faces multiple charges from federal prosecutors, including conspiracy to commit wire fraud and campaign finance violations.
Congress set to hold hearing on Sam Bankman-Fried’s crypto exchange FTX Tuesday
Ahead of his Monday arrest, Sam Bankman-Fried said he would try to shed light on what led to the crash of crypto exchange FTX at the hearing.
Alexa ‘thank my driver’ lets customers tip their deliverers. But has Amazon been stealing tips?
The new feature launched the same day the D.C. Attorney General announced a lawsuit against Amazon for allegedly stealing driver tips.
Your next Uber ride in Las Vegas could be in an autonomous vehicle
Uber will offer robotaxi rides in Las Vegas, thanks to a 10-year partnership with driverless technology company Motional.
For ‘Yellowstone’ fans, dressing up like your favorite character is as easy as scanning a QR code
The virtual platform Shop The Scenes lets fans shop for merchandise featured in TV shows or inspired by their favorite characters.
Elon Musk’s Neuralink wants people to control computers with their minds. How close are they?
After testing on monkeys, the brain implant company Neuralink has received approval from the FDA to conduct its first in-human clinical study.